nodes	percent_of_prediction	percent_of_DWPC	metapath
Tubocurarine—ACHE—prostate cancer	0.452	0.558	CbGaD
Tubocurarine—SLC22A1—prostate cancer	0.358	0.442	CbGaD
Tubocurarine—SLC22A2—Estradiol—prostate cancer	0.045	0.535	CbGbCtD
Tubocurarine—SLC22A1—Estradiol—prostate cancer	0.0391	0.465	CbGbCtD
Tubocurarine—CHRNA1—prostate gland—prostate cancer	0.00158	0.177	CbGeAlD
Tubocurarine—CHRNA2—prostate gland—prostate cancer	0.00131	0.147	CbGeAlD
Tubocurarine—CHRNB1—prostate gland—prostate cancer	0.00122	0.136	CbGeAlD
Tubocurarine—ACHE—prostate gland—prostate cancer	0.00106	0.118	CbGeAlD
Tubocurarine—CHRM2—prostate gland—prostate cancer	0.000784	0.0874	CbGeAlD
Tubocurarine—SLC22A2—renal system—prostate cancer	0.000743	0.0829	CbGeAlD
Tubocurarine—CHRNB1—testis—prostate cancer	0.000539	0.0601	CbGeAlD
Tubocurarine—SLC22A1—renal system—prostate cancer	0.000525	0.0585	CbGeAlD
Tubocurarine—ACHE—testis—prostate cancer	0.000467	0.0521	CbGeAlD
Tubocurarine—CHRNB1—lymph node—prostate cancer	0.000391	0.0436	CbGeAlD
Tubocurarine—ACHE—lymph node—prostate cancer	0.000339	0.0378	CbGeAlD
Tubocurarine—SLC22A2—Metabolism—NCOA3—prostate cancer	1.79e-05	0.000186	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SLC5A5—prostate cancer	1.79e-05	0.000186	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	1.78e-05	0.000185	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SULT2A1—prostate cancer	1.78e-05	0.000184	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP2E1—prostate cancer	1.75e-05	0.000181	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—IL6—prostate cancer	1.75e-05	0.000181	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—IGF1—prostate cancer	1.75e-05	0.000181	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—MED12—prostate cancer	1.75e-05	0.000181	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GNG5—prostate cancer	1.73e-05	0.00018	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—NQO1—prostate cancer	1.73e-05	0.000179	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CALCA—prostate cancer	1.72e-05	0.000178	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GHR—prostate cancer	1.71e-05	0.000177	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—HPGDS—prostate cancer	1.71e-05	0.000177	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—TH—prostate cancer	1.7e-05	0.000177	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP2C19—prostate cancer	1.7e-05	0.000176	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.69e-05	0.000176	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—MMP2—prostate cancer	1.69e-05	0.000175	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PRKCQ—prostate cancer	1.69e-05	0.000175	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP3A4—prostate cancer	1.69e-05	0.000175	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CXCL12—prostate cancer	1.68e-05	0.000174	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.68e-05	0.000174	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NCOA3—prostate cancer	1.67e-05	0.000173	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ACHE—prostate cancer	1.66e-05	0.000172	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP1B1—prostate cancer	1.66e-05	0.000172	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTT1—prostate cancer	1.66e-05	0.000172	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NRP1—prostate cancer	1.64e-05	0.00017	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP2A6—prostate cancer	1.64e-05	0.00017	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GGT1—prostate cancer	1.61e-05	0.000166	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—AKR1C3—prostate cancer	1.59e-05	0.000165	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—HPGDS—prostate cancer	1.59e-05	0.000165	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ADRB2—prostate cancer	1.59e-05	0.000165	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PRKACB—prostate cancer	1.59e-05	0.000164	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP2C19—prostate cancer	1.58e-05	0.000164	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—NCOA1—prostate cancer	1.58e-05	0.000164	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP17A1—prostate cancer	1.57e-05	0.000163	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP19A1—prostate cancer	1.56e-05	0.000162	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.55e-05	0.000161	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—VAV3—prostate cancer	1.55e-05	0.000161	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ACHE—prostate cancer	1.55e-05	0.00016	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTT1—prostate cancer	1.55e-05	0.00016	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PRKCQ—prostate cancer	1.53e-05	0.000159	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP2A6—prostate cancer	1.53e-05	0.000158	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—VIP—prostate cancer	1.52e-05	0.000158	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GNRH1—prostate cancer	1.52e-05	0.000158	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—RXRA—prostate cancer	1.5e-05	0.000156	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ITPR1—prostate cancer	1.5e-05	0.000156	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—NCOA2—prostate cancer	1.5e-05	0.000155	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—AKR1C3—prostate cancer	1.49e-05	0.000154	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PRKACB—prostate cancer	1.48e-05	0.000153	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LPAR1—prostate cancer	1.48e-05	0.000153	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GRP—prostate cancer	1.48e-05	0.000153	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.46e-05	0.000152	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP17A1—prostate cancer	1.46e-05	0.000152	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PLCB2—prostate cancer	1.46e-05	0.000152	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LRP2—prostate cancer	1.46e-05	0.000152	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—COMT—prostate cancer	1.45e-05	0.00015	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.45e-05	0.00015	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ADRB2—prostate cancer	1.44e-05	0.00015	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTP1—prostate cancer	1.44e-05	0.00015	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CX3CL1—prostate cancer	1.43e-05	0.000149	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—P4HB—prostate cancer	1.43e-05	0.000149	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SLC5A5—prostate cancer	1.43e-05	0.000148	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ITPR1—prostate cancer	1.42e-05	0.000147	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—VAV3—prostate cancer	1.41e-05	0.000146	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HIST1H2BG—prostate cancer	1.41e-05	0.000146	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—CXCL8—prostate cancer	1.41e-05	0.000146	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.4e-05	0.000145	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GRB7—prostate cancer	1.39e-05	0.000145	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PDE4D—prostate cancer	1.39e-05	0.000145	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NCOA2—prostate cancer	1.39e-05	0.000144	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP2E1—prostate cancer	1.39e-05	0.000144	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—NQO1—prostate cancer	1.38e-05	0.000143	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ITPR1—prostate cancer	1.36e-05	0.000141	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HIST1H4H—prostate cancer	1.36e-05	0.000141	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—TH—prostate cancer	1.36e-05	0.000141	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CXCL8—prostate cancer	1.36e-05	0.000141	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP3A4—prostate cancer	1.34e-05	0.000139	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—TYMS—prostate cancer	1.34e-05	0.000139	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SLC5A5—prostate cancer	1.33e-05	0.000138	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GNG5—prostate cancer	1.33e-05	0.000137	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTM1—prostate cancer	1.33e-05	0.000137	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP1B1—prostate cancer	1.32e-05	0.000137	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—LPL—prostate cancer	1.3e-05	0.000135	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP2E1—prostate cancer	1.3e-05	0.000135	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—CTNNB1—prostate cancer	1.3e-05	0.000134	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NQO1—prostate cancer	1.28e-05	0.000133	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GGT1—prostate cancer	1.28e-05	0.000133	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—TH—prostate cancer	1.27e-05	0.000131	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—NCOA1—prostate cancer	1.26e-05	0.000131	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP1A1—prostate cancer	1.26e-05	0.00013	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP3A4—prostate cancer	1.25e-05	0.00013	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ERCC2—prostate cancer	1.25e-05	0.000129	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP19A1—prostate cancer	1.24e-05	0.000129	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP1B1—prostate cancer	1.23e-05	0.000128	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—RXRA—prostate cancer	1.2e-05	0.000124	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GGT1—prostate cancer	1.19e-05	0.000124	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NCOA1—prostate cancer	1.17e-05	0.000122	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—MTHFR—prostate cancer	1.17e-05	0.000121	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP19A1—prostate cancer	1.16e-05	0.00012	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTHLH—prostate cancer	1.16e-05	0.00012	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TGFBR1—prostate cancer	1.16e-05	0.00012	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—COMT—prostate cancer	1.15e-05	0.00012	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTP1—prostate cancer	1.15e-05	0.000119	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PPARA—prostate cancer	1.15e-05	0.000119	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AKR1C3—prostate cancer	1.14e-05	0.000118	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ITPR1—prostate cancer	1.13e-05	0.000117	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PRKACB—prostate cancer	1.13e-05	0.000117	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—RXRA—prostate cancer	1.12e-05	0.000116	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PPP3CA—prostate cancer	1.1e-05	0.000114	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—THBS1—prostate cancer	1.1e-05	0.000114	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ANXA1—prostate cancer	1.09e-05	0.000113	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CAV1—prostate cancer	1.08e-05	0.000112	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—COMT—prostate cancer	1.08e-05	0.000112	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTP1—prostate cancer	1.07e-05	0.000111	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—TYMS—prostate cancer	1.07e-05	0.000111	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PRKCZ—prostate cancer	1.07e-05	0.000111	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTM1—prostate cancer	1.06e-05	0.000109	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ITPR1—prostate cancer	1.05e-05	0.000109	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CG—prostate cancer	1.04e-05	0.000108	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—LPL—prostate cancer	1.04e-05	0.000107	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.03e-05	0.000107	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PARP1—prostate cancer	1.03e-05	0.000107	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FGFR4—prostate cancer	1.03e-05	0.000107	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CALCA—prostate cancer	1.02e-05	0.000105	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP1A1—prostate cancer	1e-05	0.000104	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—TYMS—prostate cancer	9.96e-06	0.000103	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CXCL12—prostate cancer	9.93e-06	0.000103	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ERCC2—prostate cancer	9.93e-06	0.000103	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTM1—prostate cancer	9.84e-06	0.000102	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CG—prostate cancer	9.84e-06	0.000102	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—LPL—prostate cancer	9.66e-06	0.0001	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CG—prostate cancer	9.46e-06	9.81e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CASP9—prostate cancer	9.35e-06	9.7e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—MTHFR—prostate cancer	9.33e-06	9.68e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP1A1—prostate cancer	9.33e-06	9.67e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—INS—prostate cancer	9.31e-06	9.66e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ERCC2—prostate cancer	9.25e-06	9.59e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CD—prostate cancer	9.16e-06	9.5e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PPARA—prostate cancer	9.15e-06	9.49e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CREBBP—prostate cancer	9.12e-06	9.46e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NGFR—prostate cancer	9.06e-06	9.4e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PRKCQ—prostate cancer	9.06e-06	9.4e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MAP3K7—prostate cancer	8.96e-06	9.29e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—MTHFR—prostate cancer	8.7e-06	9.02e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CD—prostate cancer	8.65e-06	8.97e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FGF10—prostate cancer	8.61e-06	8.93e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CAV1—prostate cancer	8.61e-06	8.92e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PPARA—prostate cancer	8.53e-06	8.85e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ADRB2—prostate cancer	8.52e-06	8.84e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—JAK2—prostate cancer	8.41e-06	8.72e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—MAP2K1—prostate cancer	8.37e-06	8.68e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CD—prostate cancer	8.32e-06	8.62e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—VAV3—prostate cancer	8.31e-06	8.62e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TGFBR2—prostate cancer	8.19e-06	8.49e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—NOS3—prostate cancer	8.17e-06	8.47e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ITPR1—prostate cancer	8.06e-06	8.36e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CAV1—prostate cancer	8.02e-06	8.32e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CB—prostate cancer	7.98e-06	8.28e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CG—prostate cancer	7.84e-06	8.13e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IGF1R—prostate cancer	7.71e-06	7.99e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CXCL8—prostate cancer	7.67e-06	7.96e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—JAK2—prostate cancer	7.63e-06	7.92e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CB—prostate cancer	7.54e-06	7.82e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTGS2—prostate cancer	7.47e-06	7.75e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—INS—prostate cancer	7.42e-06	7.69e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LPL—prostate cancer	7.39e-06	7.66e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—IL2—prostate cancer	7.33e-06	7.6e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PDGFRB—prostate cancer	7.32e-06	7.59e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CG—prostate cancer	7.31e-06	7.58e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CREBBP—prostate cancer	7.27e-06	7.54e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CB—prostate cancer	7.25e-06	7.52e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ITGB3—prostate cancer	7.14e-06	7.4e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	6.97e-06	7.22e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ERBB3—prostate cancer	6.92e-06	7.18e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—INS—prostate cancer	6.92e-06	7.17e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FGFR2—prostate cancer	6.91e-06	7.17e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CD—prostate cancer	6.89e-06	7.15e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CREBBP—prostate cancer	6.78e-06	7.02e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IL2—prostate cancer	6.66e-06	6.9e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TERT—prostate cancer	6.63e-06	6.88e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTEN—prostate cancer	6.52e-06	6.76e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—NOS3—prostate cancer	6.51e-06	6.75e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CD—prostate cancer	6.42e-06	6.66e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HIF1A—prostate cancer	6.34e-06	6.58e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—EP300—prostate cancer	6.21e-06	6.44e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LEP—prostate cancer	6.19e-06	6.42e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CAV1—prostate cancer	6.14e-06	6.36e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—KDR—prostate cancer	6.07e-06	6.29e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NOS3—prostate cancer	6.07e-06	6.29e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CB—prostate cancer	6.01e-06	6.23e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTGS2—prostate cancer	5.95e-06	6.17e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ESR1—prostate cancer	5.91e-06	6.13e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—BAD—prostate cancer	5.77e-06	5.98e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CB—prostate cancer	5.6e-06	5.81e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—APC—prostate cancer	5.59e-06	5.8e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	5.59e-06	5.8e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTGS2—prostate cancer	5.55e-06	5.75e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—EGF—prostate cancer	5.53e-06	5.73e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IRS1—prostate cancer	5.53e-06	5.73e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GSK3B—prostate cancer	5.36e-06	5.56e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—INS—prostate cancer	5.29e-06	5.49e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTEN—prostate cancer	5.19e-06	5.38e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CREBBP—prostate cancer	5.18e-06	5.37e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IGF1—prostate cancer	5.12e-06	5.31e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—EGFR—prostate cancer	5.09e-06	5.28e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—EP300—prostate cancer	4.95e-06	5.13e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	4.95e-06	5.13e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	4.91e-06	5.09e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	4.87e-06	5.05e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	4.86e-06	5.04e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTEN—prostate cancer	4.84e-06	5.02e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—KRAS—prostate cancer	4.81e-06	4.99e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FGF2—prostate cancer	4.7e-06	4.88e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NOS3—prostate cancer	4.64e-06	4.81e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—EP300—prostate cancer	4.61e-06	4.78e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CA—prostate cancer	4.6e-06	4.77e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—JAK2—prostate cancer	4.51e-06	4.68e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	4.42e-06	4.58e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MDM2—prostate cancer	4.4e-06	4.56e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ERBB2—prostate cancer	4.34e-06	4.5e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	4.28e-06	4.44e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CXCL8—prostate cancer	4.12e-06	4.27e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	4.02e-06	4.17e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	3.98e-06	4.12e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CASP3—prostate cancer	3.94e-06	4.08e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IL2—prostate cancer	3.93e-06	4.08e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IL6—prostate cancer	3.91e-06	4.06e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCND1—prostate cancer	3.83e-06	3.98e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	3.8e-06	3.94e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—AKT1—prostate cancer	3.75e-06	3.89e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MMP9—prostate cancer	3.72e-06	3.86e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	3.71e-06	3.85e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTEN—prostate cancer	3.7e-06	3.84e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CA—prostate cancer	3.66e-06	3.8e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	3.61e-06	3.74e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—EP300—prostate cancer	3.53e-06	3.66e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SRC—prostate cancer	3.43e-06	3.56e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CA—prostate cancer	3.41e-06	3.54e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	3.34e-06	3.47e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—STAT3—prostate cancer	3.31e-06	3.43e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MYC—prostate cancer	3.08e-06	3.19e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	3.07e-06	3.18e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—EGFR—prostate cancer	3.01e-06	3.12e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—AKT1—prostate cancer	2.99e-06	3.1e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—KRAS—prostate cancer	2.84e-06	2.95e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—AKT1—prostate cancer	2.79e-06	2.89e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	2.61e-06	2.71e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TP53—prostate cancer	2.53e-06	2.62e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IL6—prostate cancer	2.31e-06	2.4e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AKT1—prostate cancer	2.13e-06	2.21e-05	CbGpPWpGaD
